rs1805078
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000153.4(GALC):c.550C>T(p.Arg184Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0511 in 1,612,988 control chromosomes in the GnomAD database, including 2,422 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign,other (★★). Synonymous variant affecting the same amino acid position (i.e. R184R) has been classified as Likely benign.
Frequency
Consequence
NM_000153.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GALC | NM_000153.4 | c.550C>T | p.Arg184Cys | missense_variant | 5/17 | ENST00000261304.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GALC | ENST00000261304.7 | c.550C>T | p.Arg184Cys | missense_variant | 5/17 | 1 | NM_000153.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0388 AC: 5900AN: 151994Hom.: 175 Cov.: 32
GnomAD3 exomes AF: 0.0417 AC: 10401AN: 249442Hom.: 291 AF XY: 0.0428 AC XY: 5796AN XY: 135326
GnomAD4 exome AF: 0.0523 AC: 76449AN: 1460876Hom.: 2247 Cov.: 31 AF XY: 0.0520 AC XY: 37819AN XY: 726784
GnomAD4 genome ? AF: 0.0388 AC: 5896AN: 152112Hom.: 175 Cov.: 32 AF XY: 0.0379 AC XY: 2819AN XY: 74348
ClinVar
Submissions by phenotype
not specified Benign:4
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 27, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Galactosylceramide beta-galactosidase deficiency Benign:2Other:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 01, 2021 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
other, criteria provided, single submitter | clinical testing | Invitae | Jan 06, 2019 | - pseudodeficiency allele |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 04, 2018 | This variant is associated with the following publications: (PMID: 32661301, 26865610, 26795590, 7581365, 21228398, 20981092, 22995991) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at